When it comes to Mounjaro vs Ozempic, both medications have changed the way Australians approach medical weight loss. These GLP-1 injections help control appetite, regulate blood sugar, and promote healthy, steady weight reduction. However, the results and mechanisms of each treatment differ, and understanding those differences can help patients make the right choice.
Ozempic (semaglutide), made by Novo Nordisk, mimics a natural GLP-1 hormone that controls blood sugar and appetite.
By activating GLP-1 receptors, it helps the body:
Release insulin more efficiently
Slow down digestion
Reduce hunger and cravings
These effects make Ozempic one of the most widely prescribed GLP-1 medications for weight management.
You can learn more from the Mayo Clinic’s overview of GLP-1 receptor agonists.
Mounjaro (tirzepatide), developed by Eli Lilly, acts on two hormones instead of one — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide).
This dual action helps:
Control appetite more effectively
Improve blood sugar balance
Deliver stronger fat-loss results than Ozempic
When comparing Mounjaro vs Ozempic, studies consistently show Mounjaro produces greater weight loss thanks to its dual-hormone mechanism.
Several major studies have compared the two medications directly.
A JAMA Internal Medicine trial found patients using Mounjaro lost an average of 15.3% of body weight after one year, while those on Ozempic lost about 8.3%.
A recent meta-analysis supported these findings, reporting 7.7–11.4 kg (17–25 lb) average weight loss with Mounjaro versus 5.9 kg (13 lb) for Ozempic.
Both medications can cause mild, temporary side effects such as:
Nausea
Constipation or diarrhoea
Bloating or indigestion
Because Mounjaro targets two receptors, these effects may be slightly more noticeable.
Always consult your GP for tailored advice.
In Australia, Mounjaro is usually more expensive than Ozempic, and supply can vary.
Ozempic has broader pharmacy availability, while Mounjaro is becoming more accessible.
Both Mounjaro and Ozempic are effective options for long-term weight loss. The right choice depends on:
Weight-loss goals
Budget and availability
Side-effect tolerance
Underlying health conditions
You can discuss these options with your qualified practitioner and receive a personalised GLP-1 treatment plan that suits your needs, if you are eligible.
When comparing Mounjaro vs Ozempic, evidence shows that Mounjaro tends to produce greater overall weight-loss results due to its dual-hormone action.